Work

Key Milestones in HCV Discovery and Therapeutics

Year: 2020

Type: article

Abstract: This year's Nobel Prize in Physiology or Medicine was awarded to three scientists, each of whom played an integral role in the identification of the hepatitis C virus (HCV) and the characterization of the disease it causes, chronic hepatitis C (CHC). Initially Dr. Harvey Alter, a hematologist at the Clinical Center of the National Institutes of Health in Bethesda, Maryland recognized that there were many cases of post-transfusion hepatitis, unrelated to hepatitis A virus (HAV) or hepatitis B virus (HBV), termed non-A, non-B hepatitis.

Source: The Innovation

DOI: 10.1016/j.xinn.2020.100067

Authors: Xiaoming Cheng, Marc G. Ghany

Institutions: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000